| Bioactivity | Dynamin inhibitory peptide competitively blocks binding of dynamin to amphiphysin, thus preventing endocytosis. Dynamin inhibitory peptide blocks the dopamine D3 effect on GABAA receptors[1]. | ||||||
| Invitro | Dynamin inhibitory peptide (50 μM) inhibits GABAAR endocytosis[1]. | ||||||
| Name | Dynamin inhibitory peptide | ||||||
| CAS | 251634-21-6 | ||||||
| Sequence | Gln-Val-Pro-Ser-Arg-Pro-Asn-Arg-Ala-Pro | ||||||
| Shortening | QVPSRPNRAP | ||||||
| Formula | C47H80N18O14 | ||||||
| Molar Mass | 1121.25 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Dynamin inhibitory peptide
CAS: 251634-21-6 F: C47H80N18O14 W: 1121.25
Dynamin inhibitory peptide competitively blocks binding of dynamin to amphiphysin, thus preventing endocytosis. Dynamin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.